These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 37295474)
1. Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach. Greenhawt M; Dribin TE; Abrams EM; Shaker M; Chu DK; Golden DBK; Akin C; Anagnostou A; ALMuhizi F; Alqurashi W; Arkwright P; Baldwin JL; Banerji A; Bégin P; Ben-Shoshan M; Bernstein J; Bingemann TA; Bindslev-Jensen C; Blumenthal K; Byrne A; Cahill J; Cameron S; Campbell D; Campbell R; Cavender M; Chan ES; Chinthrajah S; Comberiati P; Eastman JJ; Ellis AK; Fleischer DM; Fox A; Frischmeyer-Guerrerio PA; Gagnon R; Garvey LH; Grayson MH; Isabwe GAC; Hartog N; Hendron D; Horner CC; Hourihane JO; Iglesia E; Kan M; Kaplan B; Katelaris CH; Kim H; Kelso JM; Khan DA; Lang D; Ledford D; Levin M; Lieberman JA; Loh R; Mack DP; Mazer B; Mody K; Mosnaim G; Munblit D; Mustafa SS; Nanda A; Nathan R; Oppenheimer J; Otani IM; Park M; Pawankar R; Perrett KP; Peter J; Phillips EJ; Picard M; Pitlick M; Ramsey A; Rasmussen TH; Rathkopf MM; Reddy H; Robertson K; Rodriguez Del Rio P; Sample S; Sheshadri A; Sheik J; Sindher SB; Spergel JM; Stone CA; Stukus D; Tang MLK; Tracy JM; Turner PJ; Vander Leek TK; Wallace DV; Wang J; Wasserman S; Weldon D; Wolfson AR; Worm M; Yacoub MR J Allergy Clin Immunol; 2023 Aug; 152(2):309-325. PubMed ID: 37295474 [TBL] [Abstract][Full Text] [Related]
2. The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach. Greenhawt M; Abrams EM; Shaker M; Chu DK; Khan D; Akin C; Alqurashi W; Arkwright P; Baldwin JL; Ben-Shoshan M; Bernstein J; Bingemann T; Blumchen K; Byrne A; Bognanni A; Campbell D; Campbell R; Chagla Z; Chan ES; Chan J; Comberiati P; Dribin TE; Ellis AK; Fleischer DM; Fox A; Frischmeyer-Guerrerio PA; Gagnon R; Grayson MH; Horner CC; Hourihane J; Katelaris CH; Kim H; Kelso JM; Lang D; Ledford D; Levin M; Lieberman J; Loh R; Mack D; Mazer B; Mosnaim G; Munblit D; Mustafa SS; Nanda A; Oppenheimer J; Perrett KP; Ramsey A; Rank M; Robertson K; Sheikh J; Spergel JM; Stukus D; Tang MLK; Tracy JM; Turner PJ; Whalen-Browne A; Wallace D; Wang J; Waserman S; Witry JK; Worm M; Vander Leek TK; Golden DBK J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3546-3567. PubMed ID: 34153517 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID-19 vaccines: A systematic review and meta-analysis. Greenhawt M; Shaker M; Golden DBK; Abrams EM; Blumenthal KG; Wolfson AR; Stone CA; Krantz MS; Chu DK; Dwamena BA Allergy; 2023 Jan; 78(1):71-83. PubMed ID: 36321821 [TBL] [Abstract][Full Text] [Related]
4. Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis. Chu DK; Abrams EM; Golden DBK; Blumenthal KG; Wolfson AR; Stone CA; Krantz MS; Shaker M; Greenhawt M JAMA Intern Med; 2022 Apr; 182(4):376-385. PubMed ID: 35188528 [TBL] [Abstract][Full Text] [Related]
5. First-Dose mRNA COVID-19 Vaccine Allergic Reactions: Limited Role for Excipient Skin Testing. Wolfson AR; Robinson LB; Li L; McMahon AE; Cogan AS; Fu X; Wickner P; Samarakoon U; Saff RR; Blumenthal KG; Banerji A J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3308-3320.e3. PubMed ID: 34166844 [TBL] [Abstract][Full Text] [Related]
6. COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia. Tunbridge M; Perkins G; Lee M; Salehi T; Ryoo D; Kette F; Smith W; Gold M; Le TA; Yuson C; Hissaria P Intern Med J; 2022 Nov; 52(11):1884-1890. PubMed ID: 35848521 [TBL] [Abstract][Full Text] [Related]
7. mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach. Banerji A; Wickner PG; Saff R; Stone CA; Robinson LB; Long AA; Wolfson AR; Williams P; Khan DA; Phillips E; Blumenthal KG J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1423-1437. PubMed ID: 33388478 [TBL] [Abstract][Full Text] [Related]
8. Revaccination outcomes among adolescents and adults with suspected hypersensitivity reactions following COVID-19 vaccination: A Canadian immunization research network study. Fitzpatrick T; Yamoah P; Lacuesta G; Sadarangani M; Cook V; Pourshahnazari P; Kalicinsky C; Upton JEM; Cameron SB; Zaborniak K; Kanani A; Lam G; Burton C; Constantinescu C; Pernica JM; Abdurrahman Z; Betschel S; Drolet JP; De Serres G; Quach C; Des Roches A; Chapdelaine H; Salvadori MI; Carignan A; McConnell A; Pham-Huy A; Buchan CA; Cowan J; Hildebrand K; Top KA; Vaccine; 2024 Oct; 42(24):126078. PubMed ID: 38910092 [TBL] [Abstract][Full Text] [Related]
9. Assessment of Immediate Allergic Reactions After Immunization With the Pfizer BNT162b2 Vaccine Using Intradermal Skin Testing With the COVID-19 Vaccines. Shavit R; Maoz-Segal R; Offengenden I; Yahia SH; Maayan DM; Lifshitz Y; Niznik S; Deutch M; Elbaz E; Genaim H; Iancovici-Kidon M; Agmon-Levin N J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2677-2684. PubMed ID: 35973526 [TBL] [Abstract][Full Text] [Related]
12. Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine - United States, December 14-23, 2020. ; MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(2):46-51. PubMed ID: 33444297 [TBL] [Abstract][Full Text] [Related]
13. Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions. Pitlick MM; Sitek AN; D'Netto ME; Dages KN; Chiarella SE; Gonzalez-Estrada A; Joshi AY; Park MA Ann Allergy Asthma Immunol; 2022 Feb; 128(2):153-160. PubMed ID: 34798275 [TBL] [Abstract][Full Text] [Related]